Cargando…

Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry

(1) Background: Percutaneous left ventricle assist devices (pLVADs) demonstrated an improvement in mid-term clinical outcomes in selected patients with severely depressed left ventricular ejection fraction (LVEF) undergoing percutaneous coronary interventions. However, the prognostic impact of in-ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iannaccone, Mario, Franchin, Luca, Burzotta, Francesco, Botti, Giulia, Pazzanese, Vittorio, Briguori, Carlo, Trani, Carlo, Piva, Tommaso, De Marco, Federico, Masiero, Giulia, Di Biasi, Maurizio, Pagnotta, Paolo, Casu, Gavino, Scandroglio, Anna Mara, Tarantini, Giuseppe, Chieffo, Alaide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222801/ https://www.ncbi.nlm.nih.gov/pubmed/37240996 http://dx.doi.org/10.3390/jpm13050826

Ejemplares similares

Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry
por: Botti, Giulia, et al.
Publicado: (2022)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

A simple technique to obtain postprocedural antegrade angiographic control in single‐access Impella‐protected PCI
por: Burzotta, Francesco, et al.
Publicado: (2022)

Can we have a rationalized selection of intra-aortic balloon pump, Impella, and extracorporeal membrane oxygenation in the catheterization laboratory?
por: Russo, Giulio, et al.
Publicado: (2022)

Defining the optimal revascularization strategy during protected high-risk procedures with Impella
por: Sinning, Jan-Malte, et al.
Publicado: (2022)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Levelling the field of cardiovascular disease in women
por: Botti, Giulia, et al.
Publicado: (2022)

STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic
por: Alasnag, Mirvat, et al.
Publicado: (2022)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation
por: Attisano, Tiziana, et al.
Publicado: (2020)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI
por: van den Buijs, Deborah M. F., et al.
Publicado: (2022)

Gender Issues in Italian Catheterization Laboratories: The Gender‐CATH Study
por: Bernelli, Chiara, et al.
Publicado: (2021)

Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction
por: Marin, Federico, et al.
Publicado: (2022)

Full percutaneous biventricular support with two Impella pumps: the Bi‐Pella approach
por: Pappalardo, Federico, et al.
Publicado: (2018)

Ischemia With No Obstructive Coronary Artery Disease: Are Misdiagnosis and Undertreatment Always Behind the Corner?
por: Ghizzoni, Giulia, et al.
Publicado: (2023)

Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry
por: Burzotta, Francesco, et al.
Publicado: (2019)

Percu-Ax aortic valve implantation with a double arm approach: a case report
por: Trani, Carlo, et al.
Publicado: (2020)

The conundrum of endovascular common femoral artery treatment: a case report of lithoplasty as a viable solution
por: Trani, Carlo, et al.
Publicado: (2019)

Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the Impella
por: Sinning, Jan-Malte, et al.
Publicado: (2022)

Weaning from Impella and mobilization of Impella patients
por: Bertoldi, Letizia Fausta, et al.
Publicado: (2021)

Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Comprehensive Systematic Literature Review and Meta-Analyses
por: Ardito, Vittoria, et al.
Publicado: (2023)

Percutaneous Valve-in-Valve Treatment of a (Very Old and Fluoroscopy Invisible) Degenerated Tricuspid Prosthesis Through the Right Jugular Vein Approach
por: Aurigemma, Cristina, et al.
Publicado: (2019)

Sex-based Differences in Percutaneous Coronary Intervention Outcomes in Patients with Ischaemic Heart Disease
por: Sambola, Antonia, et al.
Publicado: (2023)

European best practice: a step forward to optimize Impella-protected percutaneous coronary intervention to improve outcome after high-risk coronary interventions
por: Werner, Nikos, et al.
Publicado: (2022)

When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock
por: Masiero, Giulia, et al.
Publicado: (2022)

Coronary stents and vascular response to implantation: literature review
por: Brancati, Marta Francesca, et al.
Publicado: (2017)

Hemodynamic support with the Impella acute 100 in patients with cardiogenic chock, or high-risk coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI)
por: Dens, J, et al.
Publicado: (2004)

Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient: Impella CP Mechanical Support During ULMCA Bifurcation Stenting
por: Bettari, Luca, et al.
Publicado: (2020)

Characterization of Three Novel IMP Metallo-β-Lactamases, IMP-89, IMP-91, and IMP-96, and Diverse bla(IMP)-Carrying Accessory Genetic Elements from Chinese Clinical Isolates
por: Li, Xinyue, et al.
Publicado: (2023)

Impella 5.0 supported oncological surgery as bridge to LVAD
por: Montisci, Andrea, et al.
Publicado: (2020)

Imps at large
Publicado: (1978)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Stent Thrombosis: Incidence, Predictors and New Technologies
por: Buchanan, Gill Louise, et al.
Publicado: (2012)

Percutaneous Salvage of an Impella Pretzel
por: Mathur, Moses, et al.
Publicado: (2019)

A Review of the Impella Devices
por: Zein, Rami, et al.
Publicado: (2022)

Percutaneous Impella Mechanical Circulatory Support Delivery Using Intravascular Lithotripsy
por: Riley, Robert F., et al.
Publicado: (2020)

Sex‐Specific Considerations in Degenerative Aortic Stenosis for Female‐Tailored Transfemoral Aortic Valve Implantation Management
por: Masiero, Giulia, et al.
Publicado: (2022)

Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non‐Obstructive Coronary Arteries: Pathogenic and Prognostic Implications
por: Montone, Rocco A., et al.
Publicado: (2021)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_r8u4iu8sgtqa6qb40sov2ge3qq